Platinum-resistant Recurrent Clear Cell Ovarian Cancer
1 competing product in clinical development for Platinum-resistant Recurrent Clear Cell Ovarian Cancer.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Niraparib + Anlotinib | Sun Pharmaceutical | Phase 2 | Completed | 35 |